Morgan Stanley (MS) Financials

Morgan Stanley’s recent financial performance shows strong earnings momentum. Based on the available quarterly data, Q2 2026 revenue increased to $21.35 billion, up 27% from $16.79 billion in Q2 2025 and roughly 59% from Q2 2023. Net income attributable to common shareholders rose to $5.44 billion, compared with $3.39 billion in Q2 2025 and $2.05 billion in Q2 2023. Diluted EPS reached $3.46, up from $2.13 a year earlier and $1.24 three years earlier.

Growth has been broad-based, although non-interest revenue remains the primary contributor. Q2 2026 non-interest income was $18.57 billion, including $2.65 billion of investment banking income, $7.14 billion from other service charges and $6.95 billion of realized and unrealized investment gains. Investment banking income increased 61% from Q2 2025, suggesting improving capital-markets activity. Net interest income also improved modestly to $2.78 billion from $2.35 billion a year earlier.

Expense growth was significant but slower than revenue growth. Total non-interest expense increased 16% year over year to $13.90 billion, while salaries and employee benefits declined to $8.19 billion from $8.54 billion in Q1 2026 but remained above the prior-year level. The provision for credit losses was $98 million in Q2 2026, down from $196 million in Q2 2025 and well below the $234 million recorded in Q1 2023.

The balance sheet has expanded considerably. Total assets reached $1.68 trillion at June 30, 2026, up from $1.35 trillion at June 30, 2025 and $1.16 trillion at June 30, 2023. Trading account securities nearly doubled over that period, reaching $973.6 billion. Deposits also grew to $446.1 billion, while cash and due from banks increased to $160.1 billion.

However, the larger balance sheet has been accompanied by increased funding needs. Long-term debt rose to $443.1 billion in Q2 2026 from $371.5 billion in Q2 2023, and short-term debt increased to $381.3 billion from $273.2 billion. Total equity grew more slowly than total assets, reaching $117.4 billion compared with $101.4 billion three years earlier.

• Strong earnings growth: Q2 2026 net income attributable to common shareholders increased approximately 61% year over year, while diluted EPS rose about 62%.
• Improving investment banking activity: Investment banking income climbed to $2.65 billion in Q2 2026, its highest level in the supplied quarterly data.
• Revenue diversification: Non-interest income has increased steadily from $11.45 billion in Q2 2023 to $18.57 billion in Q2 2026, reducing reliance on net interest income.
• Better operating leverage: Revenue grew faster than non-interest expense over the past year, helping pretax income rise to $7.35 billion from $4.62 billion in Q2 2025.
• Lower credit-loss provision: The $98 million Q2 2026 provision was half the Q2 2025 level, supporting profitability.
• Shareholder distributions continue: Morgan Stanley repurchased $1.67 billion of common stock and paid $1.68 billion in dividends during Q2 2026.
• Growing liquidity balances: Cash increased nearly 20% from Q1 2026 to $160.1 billion, providing additional balance-sheet flexibility.
• Cash increased primarily through financing: Net cash rose $26.6 billion in Q2 2026, but financing activities contributed $37.1 billion while operating cash flow was negative $2.7 billion.
• Trading-asset expansion: Trading account securities have grown sharply, which may support revenue in favorable markets but can also increase exposure to market volatility.
• Operating cash flow remains volatile: Operating cash flow was negative in Q2 2026, Q1 2026, Q4 2025 and Q3 2025, largely because of changes in operating assets and liabilities.
• Higher leverage and funding costs: Long-term and short-term debt have increased materially alongside the balance-sheet expansion, potentially increasing sensitivity to funding markets and interest rates.
• Greater exposure to market-dependent revenue: A substantial portion of Q2 2026 non-interest income came from investment gains and trading-related activities, which may not be recurring.

Overall, the statements point to a materially stronger earnings profile than Morgan Stanley reported in 2023 and 2024, supported by capital-markets recovery, higher investment gains and expanding fee businesses. Investors should nevertheless monitor whether investment banking and market-related gains remain durable, as well as whether continued asset growth and debt issuance place pressure on liquidity, capital ratios and future interest expense.

Note: Several historical standardized financial figures are marked as restated or calculated, and some interest-income and loan-related entries appear inconsistent across periods. Comparisons should therefore be interpreted as directional rather than as a substitute for Morgan Stanley’s filed financial statements.